<DOC>
	<DOCNO>NCT02746328</DOCNO>
	<brief_summary>This multiple site , proof concept feasibility study describe effect GTx-024 9 18 mg physical function female subject , protocol G200802 , ER+/AR+ breast cancer .</brief_summary>
	<brief_title>Add-on Study Protocol G200802 ( NCT02463032 ) : Effect GTx-024 Maximal Neuromuscular Function Lean Body Mass</brief_title>
	<detailed_description />
	<criteria>1 . In screen , ultimately randomize , protocol G200802 2 . Give voluntary , write sign , inform consent addon study 3 . Age 18 70 year old 4 . Physically capable mount rid stationary bicycle 5 . Subject agree significantly alter physical activity current physical training study period 1 . Subject concomitant medical condition precludes adequate study treatment compliance assessment , increase subject risk , opinion Investigator 2 . Subjects unwilling unable comply protocol 3 . Any condition per investigator ' judgement may increase subject risk</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>